Diabetes, Vol 49, Issue 5 832-837, Copyright © 2000 by American Diabetes Association

ARTICLES

Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels

DQ Shih, HM Dansky, M Fleisher, G Assmann, SS Fajans and M Stoffel
Laboratory of Metabolic Diseases, Rockefeller University, New York, New York 10021, USA.

Hepatocyte nuclear factor (HNF)-4alpha is a transcription factor that plays an important role in regulation of gene expression in pancreatic beta-cells and in the liver. Heterozygous mutations in the HNF-4alpha gene are responsible for maturity-onset diabetes of the young 1 (MODY1), which is characterized by pancreatic beta-cell-deficient insulin secretion. HNF-4alpha is a major transcriptional regulator of many genes expressed in the liver. However, no liver defect has been identified in individuals with HNF-4alpha mutations. In this study, we have identified HNF-4alpha target genes that are mainly expressed in the liver, including alpha1-antitrypsin, alpha1-antichymotrypsin, alpha-fetal protein, ceruloplasmin, IGF binding protein 1, transferrin, apolipoprotein(AI) [apo(AI)], apo(AII), apo(B), and apo(CIII). Serum levels of these proteins and Lp(a) and triglycerides were measured in 24 members of the HNF-4alpha/MODY1 RW pedigree (Q268X mutation), including 12 diabetic patients with HNF-4alpha mutations (D-HNF4+/-), 6 nondiabetic subjects with HNF-4alpha mutations (N-HNF4+/-), 6 normal relatives (N-HNF4+/+), 6 unrelated normal matched control subjects (N-HNF4+/+), and 12 matched diabetic (non-MODY1-5) patients (D-HNF4+/+). Serum levels of apo(AII), apo(CIII), lipoprotein(a) [Lp(a)], and triglyceride were significantly reduced in HNF4+/- subjects (26.9, 19.8, 12.1, and 72.1 mg/dl, respectively) compared with HNF4+/+ subjects (37.4, 26.5, 45.2, and 124.2 mg/dl, respectively) (P = 0.00001, P = 0.01, P = 0.00006, and P = 0.000003, respectively). This reduction was not found when apo(AII), apo(CIII), Lp(a), and triglyceride levels were compared in D-HNF4+/- versus N-HNF4+/- or in D-HNF4+/+ versus N-HNF4+/+ subjects, which indicates that HNF-4alpha haploinsufficiency rather than hyperglycemia is the primary cause of decreased serum protein and triglyceride concentrations. Furthermore, we determined that genetic or environmental modifiers other than HNF-4alpha do not appear to contribute to the observed decrease of HNF-4alpha-regulated serum proteins. This study demonstrates that a heterozygous HNF-4alpha mutation leads to an HNF-4alpha-dependent hepatocyte secretory defect of liver-specific proteins.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. N.T. Aryee, M. Kreppel, R. Bachmaier, A. Uren, K. Muehlbacher, S. Wagner, H. Breiteneder, J. Ban, J. A. Toretsky, and H. Kovar Single-chain Antibodies to the EWS NH2 Terminus Structurally Discriminate between Intact and Chimeric EWS in Ewing's Sarcoma and Interfere with the Transcriptional Activity of EWS In vivo. Cancer Res., October 15, 2006; 66(20): 9862 - 9869. [Abstract] [Full Text] [PDF]

				L. Palanker, A. S. Necakov, H. M. Sampson, R. Ni, C. Hu, C. S. Thummel, and H. M. Krause Dynamic regulation of Drosophila nuclear receptor activity in vivo Development, September 15, 2006; 133(18): 3549 - 3562. [Abstract] [Full Text] [PDF]

				D. Weissglas-Volkov, A. Huertas-Vazquez, E. Suviolahti, J. Lee, C. Plaisier, S. Canizales-Quinteros, T. Tusie-Luna, C. Aguilar-Salinas, M.-R. Taskinen, and P. Pajukanta Common Hepatic Nuclear Factor-4{alpha} Variants Are Associated With High Serum Lipid Levels and the Metabolic Syndrome. Diabetes, July 1, 2006; 55(7): 1970 - 1977. [Abstract] [Full Text] [PDF]

				C. W. Rowley, L. J. Staloch, J. K. Divine, S. P. McCaul, and T. C. Simon Mechanisms of mutual functional interactions between HNF-4{alpha} and HNF-1{alpha} revealed by mutations that cause maturity onset diabetes of the young Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G466 - G475. [Abstract] [Full Text] [PDF]

				A. Miura, K. Yamagata, M. Kakei, H. Hatakeyama, N. Takahashi, K. Fukui, T. Nammo, K. Yoneda, Y. Inoue, F. M. Sladek, et al. Hepatocyte Nuclear Factor-4{alpha} Is Essential for Glucose-stimulated Insulin Secretion by Pancreatic beta-Cells J. Biol. Chem., February 24, 2006; 281(8): 5246 - 5257. [Abstract] [Full Text] [PDF]

				X. Prieur, F. G. Schaap, H. Coste, and J. C. Rodriguez Hepatocyte Nuclear Factor-4{alpha} Regulates the Human Apolipoprotein AV Gene: Identification of a Novel Response Element and Involvement in the Control by Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha}, AMP-Activated Protein Kinase, and Mitogen-Activated Protein Kinase Pathway Mol. Endocrinol., December 1, 2005; 19(12): 3107 - 3125. [Abstract] [Full Text] [PDF]

				J. Ek, C. S. Rose, D. P. Jensen, C. Glumer, K. Borch-Johnsen, T. Jorgensen, O. Pedersen, and T. Hansen The Functional Thr130Ile and Val255Met Polymorphisms of the Hepatocyte Nuclear Factor-4{alpha} (HNF4A): Gene Associations with Type 2 Diabetes or Altered {beta}-Cell Function among Danes J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3054 - 3059. [Abstract] [Full Text] [PDF]

				V. Carriere, R. Vidal, K. Lazou, M. Lacasa, F. Delers, A. Ribeiro, M. Rousset, J. Chambaz, and J. M. Lacorte HNF-4-dependent Induction of Apolipoprotein A-IV Gene Transcription by an Apical Supply of Lipid Micelles in Intestinal Cells J. Biol. Chem., February 18, 2005; 280(7): 5406 - 5413. [Abstract] [Full Text] [PDF]

				C. A. Wiwi and D. J. Waxman Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2 J. Biol. Chem., February 4, 2005; 280(5): 3259 - 3268. [Abstract] [Full Text] [PDF]

				C. A. Wiwi, M. Gupte, and D. J. Waxman Sexually Dimorphic P450 Gene Expression in Liver-Specific Hepatocyte Nuclear Factor 4{alpha}-Deficient Mice Mol. Endocrinol., August 1, 2004; 18(8): 1975 - 1987. [Abstract] [Full Text] [PDF]

				D. Sauvaget, V. Chauffeton, S. Dugue-Pujol, A.-D. Kalopissis, I. Guillet-Deniau, F. Foufelle, J. Chambaz, A. Leturque, P. Cardot, and A. Ribeiro In Vitro Transcriptional Induction of the Human Apolipoprotein A-II Gene by Glucose Diabetes, March 1, 2004; 53(3): 672 - 678. [Abstract] [Full Text] [PDF]

				S. Richter, D. Q. Shih, E. R. Pearson, C. Wolfrum, S. S. Fajans, A. T. Hattersley, and M. Stoffel Regulation of Apolipoprotein M Gene Expression by MODY3 Gene Hepatocyte Nuclear Factor-1{alpha}: Haploinsufficiency Is Associated With Reduced Serum Apolipoprotein M Levels Diabetes, December 1, 2003; 52(12): 2989 - 2995. [Abstract] [Full Text] [PDF]

				Y. H. Hong, U. S. Varanasi, W. Yang, and T. Leff AMP-activated Protein Kinase Regulates HNF4{alpha} Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability J. Biol. Chem., July 18, 2003; 278(30): 27495 - 27501. [Abstract] [Full Text] [PDF]

				R. Hertz, N. Ben-Haim, A. D. Petrescu, B. Kalderon, I. Berman, N. Eldad, F. Schroeder, and J. Bar-Tana Rescue of MODY-1 by Agonist Ligands of Hepatocyte Nuclear Factor-4{alpha} J. Biol. Chem., June 13, 2003; 278(25): 22578 - 22585. [Abstract] [Full Text] [PDF]

				S. Dhe-Paganon, K. Duda, M. Iwamoto, Y.-I. Chi, and S. E. Shoelson Crystal Structure of the HNF4alpha Ligand Binding Domain in Complex with Endogenous Fatty Acid Ligand J. Biol. Chem., October 4, 2002; 277(41): 37973 - 37976. [Abstract] [Full Text] [PDF]

				J. Ferrer A Genetic Switch in Pancreatic {beta}-Cells: Implications for Differentiation and Haploinsufficiency Diabetes, August 1, 2002; 51(8): 2355 - 2362. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, S. Ellard, M. Shepherd, R. T. Howell, E. M. Parry, A. Jefferson, E. R. Levy, and A. T. Hattersley Maturity-Onset Diabetes of the Young Caused by a Balanced Translocation Where the 20q12 Break Point Results in Disruption Upstream of the Coding Region of Hepatocyte Nuclear Factor-4{alpha} (HNF4A) Gene Diabetes, July 1, 2002; 51(7): 2329 - 2333. [Abstract] [Full Text] [PDF]

				A. D. Petrescu, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier Ligand Specificity and Conformational Dependence of the Hepatic Nuclear Factor-4alpha (HNF-4alpha ) J. Biol. Chem., June 28, 2002; 277(27): 23988 - 23999. [Abstract] [Full Text] [PDF]

				T. Naiki, M. Nagaki, Y. Shidoji, H. Kojima, M. Imose, T. Kato, N. Ohishi, K. Yagi, and H. Moriwaki Analysis of Gene Expression Profile Induced by Hepatocyte Nuclear Factor 4alpha in Hepatoma Cells Using an Oligonucleotide Microarray J. Biol. Chem., April 12, 2002; 277(16): 14011 - 14019. [Abstract] [Full Text] [PDF]

				F. Blanco-Vaca, J. C. Escola-Gil, J. M. Martin-Campos, and J. Julve Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein J. Lipid Res., November 1, 2001; 42(11): 1727 - 1739. [Abstract] [Full Text] [PDF]

				D. Q. Shih, S. Screenan, K. N. Munoz, L. Philipson, M. Pontoglio, M. Yaniv, K. S. Polonsky, and M. Stoffel Loss of HNF-1{alpha} Function in Mice Leads to Abnormal Expression of Genes Involved in Pancreatic Islet Development and Metabolism Diabetes, November 1, 2001; 50(11): 2472 - 2480. [Abstract] [Full Text] [PDF]

				S. S. Fajans, G. I. Bell, and K. S. Polonsky Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young N. Engl. J. Med., September 27, 2001; 345(13): 971 - 980. [Full Text] [PDF]

				I. Leclerc, C. Lenzner, L. Gourdon, S. Vaulont, A. Kahn, and B. Viollet Hepatocyte Nuclear Factor-4{alpha} Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase Diabetes, July 1, 2001; 50(7): 1515 - 1521. [Abstract] [Full Text] [PDF]